Main Street Research’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Main Street Research's PACB Position: Q3 2026 in Review
Main Street Research sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 152,100 shares — an estimated $256K sold.
Main Street Research first reported a position in PACB in Q3 2025 and held it in 3 quarters. The position peaked at $256K in Q2 2026. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Main Street Research reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
- Main Street Research sold 152,100 Pacific Biosciences shares in Q3 2026, an estimated $256K.
- Main Street Research first reported a position in Pacific Biosciences in Q3 2025 and held it in 3 quarters.
- Main Street Research's Pacific Biosciences position peaked at $256K in Q2 2026.
- 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Main Street Research's 13F filing for Q3 2026, filed 16 Nov 2026.